Editas Medicine

Biotech & Life Sciences · Cambridge, United States · Founded 2013 · IPO 2016

Unlocking the promise of genome editing to deliver life-changing medicines

Valuation $288M

Revenue $41M

Power Law Unicorn$1–10B valuation tier Colt$25–100M revenue

Talent graph

Editas Medicine's talent

Book a demo to see the people

Employees mapped 181 incl. 2 AI specialists

Founders /100 quality score

Key operators 5 quality /100

Potential founders likely future founders

Startup mafia 9 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

17 investors on Editas Medicine's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Partners Innovation Fund

Series B+ 12 investors entered at this stage

EcoR1 Capital

Casdin Capital

Viking Global Investors

Omega Funds

T. Rowe Price

Harvard University

Alexandria Venture Investments

Khosla Ventures

Jennison Associates

Fidelity Investments

Deerfield

Boris Nikolic

Editas Medicine mafia

Startups founded by Editas Medicine alumni

Former Editas Medicine employees who went on to start their own companies. Sorted by Dealroom signal score.

Kate TherapeuticsEst. 2020

Sharif TabebordbarUnited States

Signal score85

Beam TherapeuticsEst. 2017

FZFeng ZhangUnited States

Signal score80

PairwiseEst. 2017

David LiuUnited States

Signal score77

Gate BioscienceEst. 2021

JMJordi Mata-FinkUnited States

Signal score76

Mammoth BiosciencesEst. 2017

Jennifer A. DoudnaUnited States

Signal score64

Verve TherapeuticsEst. 2018

Keith JoungUnited States

Signal score64

Stratus TherapeuticsEst. 2021

David ScaddenUnited States

Signal score62

EQRxEst. 2019

Alexis BorisyUnited States

Signal score61

AstromechEst. 2025

George ChurchUnited States

Signal score58

Book a demo to explore the full alumni network →

Global footprint

Where Editas Medicine has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States99.4%

🇮🇳 India0.6%

2 countries shown

Web traffic by country

18K monthly visits
across markets

🇺🇸 United States46.1%

🇰🇼 Kuwait23.3%

🇦🇺 Australia13.9%

🇮🇳 India4.4%

🇬🇧 United Kingdom3.9%

Top 5 markets shown

Patent intelligence

$69M patent portfolio · 71 active families

Estimated portfolio value

$69M

24.1% of market cap · 4.8× smaller than top peer Translate Bio ($336M)

71 active patent families

Where Editas Medicine innovates BiochemistryBioinformaticsCRISPRCas9Cell

Where Editas Medicine concentrates vs peers

Each axis is a top-10 topic across Editas Medicine and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Editas Medicine

An AI-synthesized read of the highest-engagement posts about Editas Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Editas Medicine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles